Related Experiment Videos
Trends in CHD in the United States
1Division of Epidemiology and Clinical Applications, National Heart, Lung and Blood Institute, Bethesda, Maryland 20892.
International Journal of Epidemiology
|January 1, 1989
Summary
Coronary heart disease (CHD) death rates declined significantly since the 1960s due to improved treatments and reduced risk factors. However, CHD remains a leading cause of death, with rising prevalence expected in an aging population.
Area of Science:
- Cardiovascular epidemiology
- Public health
- Internal medicine
Background:
- Coronary heart disease (CHD) mortality rates in the US peaked in the mid-1960s.
- Significant advancements in CHD diagnosis, prevention, and treatment have occurred.
- Risk factor profiles have shifted, with notable changes in lifestyle and medical management.
Purpose of the Study:
- To analyze trends in Coronary Heart Disease (CHD) mortality and morbidity in the United States.
- To identify factors contributing to observed changes in CHD outcomes.
- To project future trends in CHD prevalence.
Main Methods:
- Analysis of historical mortality data for Coronary Heart Disease (CHD).
- Review of trends in risk factors such as smoking, blood pressure, cholesterol, and diet.
- Assessment of changes in medical infrastructure and treatment availability.
Main Results:
- CHD death rates declined significantly after the mid-1960s, with greater reductions in acute myocardial infarction (AMI) and specific demographic groups.
- In-hospital fatality rates decreased, while incidence trends remain uncertain.
- Risk factor modifications, including reduced smoking, controlled hypertension, and dietary shifts, contributed to the decline.
- Obesity prevalence has increased, posing a future challenge.
Conclusions:
- While significant progress has been made in reducing CHD mortality, it remains a leading cause of death.
- An aging population and prolonged survival of CHD patients are expected to increase overall prevalence.
- Continued public health efforts and medical advancements are crucial for managing the future burden of CHD.